✦ LIBER ✦

Aspects of mTOR biology and the use of mTOR inhibitors in non-Hodgkin’s lymphoma

✍ Scribed by Luciano Jose Costa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the PI3K/AKT/mTOR Pathway in N

✍ Jonathan H. Schatz 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 262 KB

A Phase II trial of the oral mTOR inhibi

✍ Patrick B. Johnston; David J. Inwards; Joseph P. Colgan; Betsy R. Laplant; Brian 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Optimising the use of mTOR inhibitors in

✍ Russ, Graeme R 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 178 KB

Everolimus in relapsed Hodgkin's lymphom

✍ Simon Rule 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Targeting tumorigenesis: development and

✍ RuiRong Yuan; Andrea Kay; William J Berg; David Lebwohl 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 607 KB

Noninfectious pneumonitis with the use o

✍ Peddi, Parvin F.; Shatsky, Rebecca A.; Hurvitz, Sara A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 635 KB